About Institutional Biosafety Committee

The Institutional Biosafety Committee is charged with reviewing all registrations for research, teaching, and training that involve the use of recombinant DNA (rDNA)at Georgia Tech and for ensuring that the proposed activities comply with the federal regulations and institute policies governing these activities. The Institutional Biosafety Committee is constituted in accordance with the National Institutes of Health Guidelines for Research involving Recombinant DNA Molecules; members are appointed by the Senior Vice Provost for Research and Innovation.
The Office of Research Compliance provides administrative support to the committee and is responsible for maintaining Georgia Tech’s registration with the National Institutes of Health’s Office of Biotechnology Activities (OBA).  It is Georgia Tech policy that all activities involving rDNA must be approved prior to their initiation. The Institutional Biosafety Committee generally meets quarterly, as needed to review registrations proposing use of recombinant DNA.
For assistance with Biohazards, etiological agents, or pathogenic organisms, please consult Environmental Health & Safety  at 404.894.6119 or 404.894.9381 or email Lee Zacarias or Lisa Brindel.